Machine Learning and Rare Diseases: Can Algorithms Connect Symptoms That Physicians Rarely See Together?

Diagnosing a medical condition is often described as a process of identifying symptoms, conducting examinations, reviewing medical history and selecting appropriate tests. In many common diseases, physicians can draw on years of experience because they encounter similar patterns repeatedly. Rare diseases create a very different diagnostic environment. A physician may see a particular disorder only once or never encounter it during routine practice, while its symptoms may resemble those of much more common conditions.

This creates a fundamental information problem. A patient may visit several doctors with symptoms that appear unrelated when considered individually. Fatigue may suggest one condition, digestive problems another, unusual laboratory findings a third and a neurological symptom something else entirely. The underlying disease may only become apparent when these seemingly disconnected observations are considered together.

Machine learning is attracting attention because algorithms can analyse large collections of clinical information and search for patterns across symptoms, laboratory results, medical histories, images and genetic data. Instead of asking only whether one symptom corresponds to one disease, computational systems can examine combinations of characteristics that may be difficult to recognise from individual clinical encounters.

Research into artificial intelligence and rare diseases is expanding rapidly, particularly in genetic analysis, clinical data processing, imaging-based phenotyping and diagnostic decision support. However, machine learning is not a replacement for medical expertise. Its potential lies in helping clinicians identify patterns, prioritise possibilities and integrate information that may otherwise remain fragmented.

Why Rare Diseases Are Difficult to Diagnose

Rare diseases present a distinctive diagnostic challenge because rarity changes the amount of experience available to individual physicians. Even when a physician is highly skilled, a condition that affects a very small number of people may not appear frequently enough in everyday clinical practice to become immediately recognisable.

The problem becomes more complicated because many rare diseases do not have a single distinctive symptom. Patients may experience combinations of relatively common symptoms, and different patients with the same disorder may present differently. Some conditions also affect multiple organs, creating a clinical picture that is distributed across different medical specialties.

Recent research on rare disease diagnosis has highlighted prolonged diagnostic journeys, heterogeneous symptoms and limited clinical awareness as continuing challenges. A 2025 Scientific Reports consensus paper noted that people with rare diseases can experience months or years before diagnosis because of low prevalence, heterogeneous clinical presentation and limited awareness among healthcare professionals.

This is where computational pattern recognition becomes potentially valuable. An algorithm does not need to have personally encountered a patient with a particular disease. If it has been trained or otherwise designed using appropriate data, it can examine relationships across many documented cases and identify combinations that deserve further clinical attention.

The Difference Between Seeing Symptoms and Connecting Symptoms

Physicians routinely interpret symptoms in context, but clinical information is often fragmented. A patient may see different specialists at different times, and each consultation may focus on a particular body system.

A machine learning system can potentially analyse information across these encounters. A repeated laboratory abnormality recorded years apart, an unusual combination of symptoms, a pattern in medical imaging and a particular family history may become more meaningful when considered together.

This does not mean that an algorithm understands the patient in the same way a physician does. Rather, machine learning can identify statistical or computational relationships within large datasets. A clinician can then determine whether the suggested pattern makes biological and clinical sense.

Research on AI applications in rare diseases increasingly emphasises the integration of different forms of evidence. Recent work has examined approaches that combine phenotypic information with genetic and other clinical data, while newer systems are being investigated for identifying rare disease patterns from medical records.

The potential value is therefore not simply faster calculation. It is the ability to connect information that may otherwise remain separated.

How Machine Learning Finds Patterns

Machine learning involves computational methods that learn relationships from data. In healthcare, these relationships can involve symptoms, laboratory measurements, medical images, genetic variants, clinical notes and other forms of information.

Suppose a dataset contains thousands of patient records. Each record may contain hundreds or thousands of individual pieces of information. An algorithm can be trained to identify combinations associated with particular diagnoses or outcomes.

For rare diseases, this is particularly challenging because the number of confirmed cases may be very small. Researchers therefore investigate approaches such as transfer learning, data augmentation and methods designed to learn effectively from limited examples. A recent review of AI in rare disease diagnosis specifically identified limited data availability as a major challenge and discussed techniques such as transfer learning as potential ways of addressing it.

The goal is not simply to find the rare disease with the largest number of matching symptoms. A useful system needs to consider the relative importance of individual findings, relationships between them and the wider clinical context.

Phenotype Matching and Rare Disease Diagnosis

One of the most promising applications is phenotype-driven diagnosis. A phenotype refers to observable characteristics of an individual, including physical findings, symptoms, laboratory results and other measurable traits.

In rare genetic disorders, a patient may present with a combination of features that collectively resembles a known disease pattern. Machine learning can compare these characteristics with information from databases and previously characterised patients.

Recent research has explored few-shot learning for phenotype-driven diagnosis of rare genetic diseases. Such approaches are particularly interesting because rare diseases naturally create a situation in which training examples may be limited.

The underlying idea is important. Instead of requiring an algorithm to see thousands of examples of every rare disease, researchers are investigating whether models can use relationships between diseases and phenotypic features to reason from relatively limited examples.

This remains an active research area rather than a universally established clinical method. Nevertheless, it illustrates why machine learning may be particularly relevant to rare disease medicine.

Electronic Health Records as a Hidden Source of Clues

Electronic health records contain information that can extend across years of medical care. A patient’s record may include diagnoses, symptoms, prescriptions, laboratory results, imaging reports, specialist consultations and hospital admissions.

For rare diseases, this longitudinal information can be valuable because the diagnostic pattern may emerge gradually rather than appearing during one appointment.

Recent research has explored labelled medical-record datasets specifically for machine learning approaches to earlier rare disease detection. Researchers have noted that rare disease patients may have multiple clinical encounters before the underlying condition is recognised, creating opportunities for computational analysis of accumulated records.

Natural language processing can add another dimension. Important information is often contained in free-text clinical notes rather than structured database fields. AI systems can potentially extract symptoms, observations and relationships from these narratives and make them available for computational analysis.

A 2025 review of AI in rare disease diagnosis identified natural language processing for clinical data extraction as one of the important areas of development alongside genetic analysis and imaging-based phenotyping.

Genetics Adds Another Layer of Complexity

Many rare diseases have genetic causes, making genomic information particularly relevant to diagnosis. Modern sequencing technologies can identify large numbers of genetic variants, but determining which variants are actually responsible for disease can be difficult.

Machine learning can assist researchers in prioritising candidate variants by considering genetic, phenotypic and biological information together. This can reduce the amount of information that specialists need to examine manually.

AI-based approaches have been investigated for next-generation sequencing analysis, variant interpretation and rare disease diagnosis. Researchers have also explored the integration of genetic information with phenotype data because a genetic variant becomes more informative when it is consistent with the patient’s clinical presentation.

The future of rare disease diagnosis may therefore involve a combination of clinical observations and computational genomic analysis rather than relying exclusively on either source.

Learning From Symptoms That Appear Unrelated

The central promise of machine learning in rare diseases lies in its ability to examine relationships between seemingly unrelated observations.

Consider a hypothetical patient who experiences recurring gastrointestinal symptoms, unusual fatigue, a particular pattern of neurological complaints and an abnormal laboratory measurement. Each symptom alone could be associated with numerous common conditions. A physician may reasonably investigate those conditions first.

An algorithm analysing a large dataset could potentially recognise that the combination, rather than any individual symptom, appears disproportionately associated with a particular rare disorder.

This does not mean the algorithm has discovered a diagnosis. It has identified a pattern that may warrant further investigation. The clinician still needs to determine whether the pattern fits the patient’s circumstances and whether confirmatory testing supports the possibility.

This distinction is crucial because machine learning is fundamentally pattern-oriented. Clinical diagnosis requires interpretation, causal reasoning, patient communication, examination and appropriate testing.

Patient-Reported Information Could Improve the Picture

Medical records do not contain every aspect of a person’s experience. Patients may notice patterns in daily life that are difficult to capture during short clinical appointments.

Patient-oriented questionnaires can provide structured information about symptoms and day-to-day experiences. A 2024 systematic review examined research using patient-oriented questionnaires and machine learning for rare disease diagnosis, identifying the potential of combining patient-reported information with computational methods.

This approach could be especially relevant for symptoms that fluctuate or are difficult to quantify through conventional tests.

For example, a patient might report that a symptom consistently appears after particular activities, changes at certain times or occurs alongside another seemingly unrelated experience. When thousands of such observations are analysed together, they may contribute to a more detailed understanding of disease patterns.

Patient-generated data therefore has the potential to complement formal clinical measurements rather than replace them.

Medical Imaging and AI-Based Phenotyping

Rare disease diagnosis can also involve medical imaging. Certain disorders produce subtle patterns in the structure or appearance of organs, bones, tissues or other anatomical features.

Deep learning and computer vision systems can analyse images and identify patterns that may be difficult to detect consistently through manual review. AI research in rare diseases has therefore expanded beyond symptoms and records into imaging-based phenotyping.

A recent review of AI in rare disease diagnosis identified imaging-based phenotyping as one of the major areas of current research.

The potential is particularly interesting when imaging information is combined with clinical and genetic data. A system could potentially consider the patient’s symptoms, laboratory results, image characteristics and genomic information together.

Such multimodal analysis could provide a richer representation of the patient than any single data source.

The Problem of Small Datasets

The greatest strength of machine learning in rare disease research is also one of its biggest challenges: machine learning generally benefits from data, while rare diseases naturally produce limited numbers of confirmed cases.

A common disease may generate enormous datasets containing millions of patient records. An ultra-rare condition may have only a small number of documented patients in a particular health system.

Small datasets increase the risk of overfitting, where a model learns patterns specific to its training data but performs poorly on new patients. Data from one hospital may also differ from data collected elsewhere because of differences in patient populations, documentation practices and diagnostic procedures.

A 2024 scoping review of AI in rare disease treatment found that nearly half of the reviewed articles highlighted data scarcity or small sample sizes as a challenge.

Researchers are therefore investigating federated learning, transfer learning, synthetic data, international data collaboration and other strategies that may help overcome limited sample sizes while maintaining appropriate privacy protections.

Explainability Matters in Medical AI

A machine learning model may produce a prediction without providing a clinically satisfying explanation of how it reached that result. This creates an important challenge in healthcare.

A physician needs to know not only what a system suggests but also why that suggestion deserves consideration. If an algorithm identifies a rare disease, clinicians may need to understand which symptoms, laboratory findings, images or genetic features contributed to the result.

Explainable AI aims to make computational reasoning more understandable. In rare disease diagnosis, this could allow clinicians to see the specific features that caused a system to prioritise a particular condition.

However, explanations generated by an AI system should not automatically be treated as proof of causation. Interpretability methods themselves have limitations, and clinical validation remains essential.

False Positives and Diagnostic Overload

Machine learning can potentially identify patterns that humans overlook, but this ability creates another problem: not every unusual pattern indicates a rare disease.

If an algorithm generates too many alerts, clinicians may become overwhelmed by possibilities that do not ultimately lead to meaningful diagnoses. This could increase unnecessary testing, anxiety and healthcare costs.

Research into diagnostic decision-support systems has identified concerns involving accuracy, data protection, adoption and clinical integration. A systematic review found that such systems show potential for supporting rare disease diagnosis but remain insufficiently mature for universal clinical use.

A successful system therefore needs an appropriate balance between sensitivity and specificity. It must identify meaningful possibilities without turning every unusual symptom combination into an alarm.

Machine Learning Should Support Physicians, Not Replace Them

Rare disease diagnosis requires more than pattern recognition. Physicians must understand the patient’s history, examine physical findings, assess competing explanations, consider the consequences of testing and communicate uncertainty.

Machine learning can potentially function as an additional layer of clinical decision support. It can search large datasets, identify possible disease associations and prioritise information for further investigation.

Recent work on AI-supported rare disease care has emphasised the value of a patient–clinician–AI model in which computational systems support rather than replace specialist review. Researchers have also highlighted the importance of confirmatory testing and clinical follow-up.

This human-in-the-loop model may be particularly important for rare diseases because individual cases can differ significantly from textbook descriptions.

The Future of Rare Disease Diagnosis

The future may involve diagnostic systems that continuously analyse information across healthcare encounters rather than waiting for a clinician to recognise a rare disease manually.

A patient could have years of medical information distributed across primary care, hospitals, laboratories and specialist clinics. AI systems could potentially identify recurring patterns and alert clinicians when the overall combination becomes unusual enough to warrant investigation.

Genomic information could then be integrated with phenotypic and imaging data. Patient-reported symptoms could provide additional context, while clinical specialists could evaluate the resulting hypotheses.

Such a system would not eliminate diagnostic uncertainty. Instead, it could help transform fragmented information into a more coherent clinical picture.

The field is moving toward this type of multimodal approach. Recent research describes AI applications spanning genetic analysis, clinical records, imaging, phenotype matching and treatment research, while newer work is examining how these technologies can be integrated into broader rare disease care pathways.

Conclusion

Rare diseases present one of medicine’s most difficult information challenges. Individual symptoms are often common, clinical presentations can vary widely, and physicians may have limited opportunities to encounter a particular disorder during routine practice.

Machine learning offers a different way of approaching this problem. Instead of examining symptoms independently, algorithms can analyse combinations of clinical features, laboratory findings, medical histories, images, patient-reported information and genetic data. This creates the possibility of identifying patterns that might otherwise remain fragmented across multiple appointments or specialties.

Research already demonstrates potential in phenotype matching, electronic health record analysis, natural language processing, imaging, genetic variant interpretation and patient-oriented questionnaires.

Yet the technology has important limitations. Rare diseases generate small datasets, clinical information can be incomplete, algorithms can produce false positives, and models developed in one population may not perform equally well elsewhere. Privacy, transparency, explainability and clinical validation also remain central concerns.

The most useful role for machine learning may therefore be as a pattern-discovery and decision-support system working alongside physicians. An algorithm can examine millions of relationships, but a clinician must still determine what those relationships mean for an individual patient.

If these technologies continue to improve while remaining subject to rigorous validation and human oversight, machine learning could help medicine recognise connections between symptoms that are individually familiar but collectively unusual. For patients whose diagnostic journeys span years and multiple specialties, the ability to bring scattered clues together could become an important part of the future of rare disease diagnosis.

Online Internship with Certificate